Skin and Connective Tissue Diseases vitiligo
Conditions
Interventions
methotrexate treated group
placebo treated patients
Sponsors
alazhar university ,faculty of medicine for girls
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: -Vitiligo patients who don't use any systemic or local medication for at least one month prior to the onset of the study. -Age more than 18 years -both males and females
Exclusion criteria
Exclusion criteria: -Patients have systemic diseases(e.g. pulmonary diseases, hepatic diseases, neutropenia,anemia,pancytopenia) -Patients have a history or an active infection with Hepatitis C. -Pregnant and lactating females -Patients with age less than 18 -Patients suffering from any dermatological disease other than vitiligo.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -To evaluate the safety and efficacy of methotrexate loaded nano biopolymer as atopical treatment for vitiligo. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the possibility of methotrexate loaded nano biopolymer to be an alternative for conventional vitiligo treatments. | — |
Countries
Egypt
Contacts
Public ContactRana Mohamed Tarek Mohamed Fathy Gheith
dermatologist
Outcome results
None listed